Related Experiment Video
Updated: Jan 30, 2026

Non-invasive Optical Measurement of Cerebral Metabolism and Hemodynamics in Infants
Published on: March 14, 2013
CD71+ erythroid cells as a potential early biomarker for hemodynamic significant patent ductus arteriosus in preterm
Ju Ae Shin1, Jae Young Lee1, Jeongmin Shin1
1Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Insights
Elevated CD71+ erythroid cells (CECs) in preterm infants can predict the risk of hemodynamically significant patent ductus arteriosus (hsPDA). Early CEC measurement may improve early detection and intervention for hsPDA in neonates.
Area of Science:
- Neonatal Medicine
- Pediatric Cardiology
- Hematology
Background:
- Hemodynamically significant patent ductus arteriosus (hsPDA) in preterm infants is linked to poor outcomes.
- Early identification of infants at risk for hsPDA is crucial for timely intervention.
- Perinatal inflammation is a known risk factor for PDA, and CD71+ erythroid cells (CECs) possess immunomodulatory properties.
Purpose of the Study:
- To investigate the association between CEC levels and the development of hsPDA in preterm infants.
- To determine if CECs can serve as an early predictive biomarker for hsPDA.
Main Methods:
- A prospective study involving 108 preterm infants (born before 37 weeks gestation).
- Quantification of CEC levels using flow cytometry within 12 hours of birth.
- Assessment of hsPDA via echocardiography between days 3 and 7 post-birth.
Main Results:
- CEC levels showed a significant inverse correlation with gestational age and hematologic parameters (hemoglobin, RBC, WBC, platelets).
- Infants who developed hsPDA had significantly higher CEC levels compared to those without hsPDA.
- Elevated CEC levels and lower white blood cell count were identified as independent predictors of hsPDA.
Conclusions:
- Early measurement of CEC levels can identify preterm infants at high risk for hsPDA.
- CECs show potential as a predictive biomarker for hsPDA, aiding in risk stratification and timely intervention.
- Further research is warranted to understand the underlying mechanisms connecting CECs and hsPDA.
Introduction:
Hemodynamically significant patent ductus arteriosus (hsPDA) in preterm infants is associated with increased mortality and morbidity. Early and accurate identification of infants at risk for PDA is critical for improving outcome. Perinatal inflammation is a known risk factor of PDA. CD71+ erythroid cells (CECs) are immature red blood cells with immunomodulatory roles and show variable abundance in preterm infants. We aimed to examine the proportion of CECs in preterm infants and investigate association with PDA.
Methods:
In this prospective study, we evaluated the association between CEC levels and the development of hsPDA in a cohort of 108 preterm infants born before 37 weeks of gestation. CEC levels were quantified by flow cytometry within 12 hours of birth. The presence of hsPDA was assessed by echocardiography between days 3 and 7 after birth.
Results:
CEC levels showed a significant inverse relationship with gestational age (CEC(%) = -0.4419 × Gestational Age + 18.7029, p<0.001). CEC levels were also inversely correlated with hemoglobin, red blood cells, white blood cells, and platelets (all p < 0.05). Infants who developed hsPDA had significantly higher CEC levels (7.5 ± 2.8% vs. 4.4 ± 1.7%, p < 0.0001), together with lower values of these hematologic parameters than infants without hsPDA. Multivariable logistic regression identified elevated CECs levels (odds ratio: 2.048, 95% CI: 1.326-3.162, p = 0.0012) and lower white blood cell count (odds ratio: 0.782, 95% CI: 0.620-0.986, p = 0.038) as independent predictors of hsPDA. Additionally, CECs levels were inversely correlated with hemoglobin, red blood cells, white blood cells, and platelets (p<0.05).
Discussion:
These results suggest that early measurement of CEC levels can identify preterm infants at high risk for hsPDA prior to echocardiographic diagnosis. As a potential predictive biomarker, CECs may improve risk stratification and guide timely intervention, ultimately enhancing clinical outcomes. Further research is needed to elucidate the mechanisms linking CECs to hsPDA.
Related Concept Videos
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Potential Energy
Drug Dosing: Infants and Children
Standard Electrode Potentials
The Resting Membrane Potential

